# FDA Inspection 963196 - Akrimax Pharmaceuticals, LLC - February 17, 2016

Source: https://www.keypedia.com/records/fda_inspections/akrimax-pharmaceuticals-llc/067f2b5e-4c56-4709-8822-6bd019eb4c76
Source feed: FDA_Inspections

> FDA Inspection 963196 for Akrimax Pharmaceuticals, LLC on February 17, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 963196
- Company Name: Akrimax Pharmaceuticals, LLC
- Inspection Date: 2016-02-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 740444 - 2011-08-19](https://www.keypedia.com/records/fda_inspections/akrimax-pharmaceuticals-llc/89525fc6-6104-4aac-bdd9-86f8f72de163)

Company: https://www.keypedia.com/companies/akrimax-pharmaceuticals-llc/788470fc-5bed-4c88-b3f8-eecfa0e7853d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c